Founded in 2020 by Chilean biochemist Bernardo Pollak, Meristem is using precise gene editing techniques to develop local ...

Biotech company Factor Bioscience sued rival Cellectis and pharmaceutical giant AstraZeneca in Delaware federal court on ...

Katy Rezvani, MD, PhD, discusses advancements in CAR-NK cell therapy, focusing on enhancing antitumor efficacy while ensuring safety through precise gene editing techniques.

Have you ever looked into the face of evil? Today, we’re taking a horrifying journey into the depths of the worst of humanity ...

While headlines focus on bringing back the woolly mammoth, the most significant impact of this research lies in its immediate ...

Gene editing in plants remains challenging, with the traditional non-homologous end-joining (cNHEJ) repair pathway often ...

The more that people know about gene editing, the more likely they are to feel it is safe to use in agriculture and medicine, according to a survey of more than 4,500 people across the United States.

Katy Rezvani, MD, PhD, discusses advancements in CAR-NK cell therapy, focusing on enhancing antitumor efficacy while ensuring safety through precise gene editing techniques. Dr Katy Rezvani reveals ...

Biotech firm Factor Bioscience has filed a lawsuit against Cellectis and AstraZeneca, accusing the companies of allegedly ...

Reliable detection of NGT products is possible and essential for transparency and consumer trust, say researchers ...

According to the DataM Intelligence, The global cancer gene therapy market size was valued as US$ 3.97 billion in 2024 and is expected to reach US$ 19.97 billion by 2033, growing at a CAGR of 19.8% ...

Potato chips and French fries can now be healthier. Understand the science behind reducing cancer risks in your favorite snacks.